Enter Note Done
Go to previous page in this tab
Session
  • Presentation | Gaining CONFIDENCE: Using Finerenone and SGLT2i to Optimize Cardiac and Kidney Outcomes
  • Population
  • Share Icon
    Bookmark Icon
  • Racial and Ethnic Differences in the Simultaneous Initiation of Finerenone and Empagliflozin on Urinary Albumin-to-Creatinine Ratio: The CONFIDENCE Trial
    • Schedule
    Notes
  • Moderated Digital Poster 19‚ Population Science Zone
    MDP1988
    Set Timezone

Generic 'disconnected' Message
Tracy Makuvire, Brigham and Women's Hosp, Harvard Medical Sch, Boston, MA; Jennifer Green, Duke Univ Sch of Med, Durham, NC; Janet B. McGill, Washington Univ in St. Louis, St Louis, MO; Amy Mottl, Univ of North Carolina Kidney Ctr, Chapel Hill, NC; Julio Rosenstock, Univ of Texas Southwestern Medical Ctr, Dallas, TX; Peter Rossing, Steno Diabetes Ctr Copenhagen and Univ of Copenhagen, Copenhagen, Denmark; Muthiah Vaduganathan, Brigham and Women's Hosp, Harvard Medical Sch, Boston, MA; Masaomi Nangaku, The Univ of Tokyo Graduate Sch of Med, Tokyo, Japan; Li Li, Bayer AG, Berlin, Germany; Charlie Scott, Bayer Healthcare Inc, Whippany, NJ; Brian Claggett, Brigham and Women's Hosp, Harvard Medical Sch, Boston, MA; Rajiv Agarwal, Richard L. Roudebush VA Medical Ctr and Indiana Univ Sch of Med, Indianapolis, IN
Communities
Navigation
Session Type
Onsite Viewing
Main Session